Continuum Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Continuum Advisory's ELV Position: Q2 2026 in Review
Continuum Advisory opened a new position in Elevance Health (ELV) in Q2 2026: 1,018 shares worth $394K. The stake represents 0.03% of the portfolio and ranks #336 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in ELV as recently as Q3 2025.
Continuum Advisory first reported a position in ELV in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.05M in Q4 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Continuum Advisory held 1,018 shares of Elevance Health worth $394K as of Q2 2026.
- Elevance Health was a new Continuum Advisory position in Q2 2026.
- Elevance Health made up 0.03% of Continuum Advisory's portfolio in Q2 2026, its #336 holding.
- Continuum Advisory first reported a position in Elevance Health in Q1 2022 and has held it in 16 quarters since.
- Continuum Advisory's Elevance Health position peaked at $1.05M in Q4 2023.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.